Skip to main content
SpringerLink
Log in

The Metabolic Syndrome in Mid-Aged Women

  • Chapter
  • First Online:
Menopause

Abstract

The metabolic syndrome (METS) is diagnosed by the presence of three of the following findings: obesity, hyperglycemia, hypertriglyceridemia, low high-density lipoprotein cholesterol, and hypertension. Many features of the syndrome are related to insulin resistance and excessive weight. Diagnostic criteria may vary from one institution to another and the prevalence of the METS, and its components, increases after the menopause, with age and sedentary lifestyle. The syndrome is accompanied with alterations of cytokines, digestive hormones, and antioxidative capacity. Associated comorbidities include among others insulin resistance and type 2 diabetes mellitus, cardiovascular disease, and other conditions such as sexual dysfunction, insomnia, genitourinary pathology, and cognitive impairment. Clinical interventions for the METS include diet and appropriate nutrition, exercise, preservation of the ovarian function and hormone therapy, and/or individual treatment of each of its components. The Mediterranean diet improves insulin sensitivity, produces favorable metabolic changes, and modifies the digestive microbioma. Regular vigorous exercise reduces body weight and potentiates the effects of a healthy diet. Menopausal hormone therapy may be considered if indicated for specific complaints.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marañon G. Über hypertonie und zuckerkrankheit. Zentralblatt für Innere Medizin. 1922;43:169–76.

    Google Scholar 

  2. Kylin E. Studien ueber das hypertonie-hyperglykaemie-hyperurikaemiesyndrom. Zentralblatt für Innere Medizin. 1923;44:105–27.

    Google Scholar 

  3. Avogaro P, Crepaldi G, Enzi G, Tiengo A. Associazione di iperlipidemia, diabete mellito e obesità di medio grado. Acta Diabetol Lat. 1967;4:36–41.

    Article  Google Scholar 

  4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  CAS  PubMed  Google Scholar 

  5. Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril. 2009;92:1171–86.

    Article  PubMed  Google Scholar 

  6. van Dijk GM, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: the top 11 conditions have common solutions. Maturitas. 2015;80:24–30.

    Article  PubMed  Google Scholar 

  7. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387:1377–96.

    Article  Google Scholar 

  8. Chedraui P, Pérez-López FR. Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population. Climacteric. 2013;16(Suppl 1):85–95.

    Article  CAS  PubMed  Google Scholar 

  9. Ju SY, Jeong HS, Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab. 2014;99:1053–63.

    Article  CAS  PubMed  Google Scholar 

  10. Remely M, Haslberger AG. The microbial epigenome in metabolic syndrome. Mol Asp Med. 2017;54:71–7. doi:10.1016/j.mam.2016.09.003. PubMed PMID: 27670623.

    Article  CAS  Google Scholar 

  11. Hand TW, Vujkovic-Cvijin I, Ridaura VK, Belkaid Y. Linking the microbiota, chronic disease, and the immune system. Trends Endocrinol Metab. 2016;27(12):831–43. doi:10.1016/j.tem.2016.08.003. PubMed PMID: 27623245.

    Article  CAS  PubMed  Google Scholar 

  12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.

    Article  CAS  PubMed  Google Scholar 

  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Article  Google Scholar 

  14. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF Communications; 2006. www.idf.org.

    Google Scholar 

  15. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  16. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Rep. 2009;13:1–7.

    Google Scholar 

  17. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007;18:280–5.

    Article  CAS  PubMed  Google Scholar 

  18. Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14:3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92:895–901.

    Article  CAS  PubMed  Google Scholar 

  20. Trikudanathan S, Pedley A, Massaro JM, Hoffmann U, Seely EW, Murabito JM, et al. Association of female reproductive factors with body composition: the Framingham Heart Study. J Clin Endocrinol Metab. 2013;98:236–44.

    Article  CAS  PubMed  Google Scholar 

  21. Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol. 2006;22:447–54.

    Article  CAS  PubMed  Google Scholar 

  22. Fernández-Alonso AM, Cuadros JL, Chedraui P, Mendoza M, Cuadros AM, Pérez-López FR. Obesity is related to increased menopausal symptoms among Spanish women. Menopause Int. 2010;16:105–10.

    PubMed  Google Scholar 

  23. Cuadros JL, Fernández-Alonso AM, Chedraui P, Cuadros AM, Sabatel RM, Pérez-López FR. Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronized oral progesterone. Gynecol Endocrinol. 2011;27:156–62.

    Article  CAS  PubMed  Google Scholar 

  24. Chedraui P, Jaramillo W, Pérez-López FR, Escobar GS, Morocho N, Hidalgo L. Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol. 2011;27:685–91.

    Article  CAS  PubMed  Google Scholar 

  25. Chedraui P, Escobar GS, Ramírez C, Pérez-López FR, Hidalgo L, Mannella P, et al. Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol. 2012;28:787–91.

    Article  CAS  PubMed  Google Scholar 

  26. Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010;17:511–31.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chedraui P, Pérez-López FR, Escobar GS, Palla G, Montt-Guevara M, Cecchi E, et al. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014;79:86–90.

    Article  CAS  PubMed  Google Scholar 

  28. Chedraui P, Escobar GS, Pérez-López FR, Palla G, Montt-Guevara M, Cecchi E, et al. Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas. 2014;77:370–4.

    Article  CAS  PubMed  Google Scholar 

  29. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899–907.

    Article  CAS  PubMed  Google Scholar 

  30. Otunctemur A, Dursun M, Ozbek E, Sahin S, Besiroglu H, Koklu I, et al. Effect of metabolic syndrome on sexual function in pre- and postmenopausal women. J Sex Marital Ther. 2015;41:440–9.

    Article  PubMed  Google Scholar 

  31. Chedraui P, Pérez-López FR, Blümel JE, Hidalgo L, Barriga J. Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints. Gynecol Endocrinol. 2010;26:86–92.

    Article  CAS  PubMed  Google Scholar 

  32. Maseroli E, Fanni E, Cipriani S, Scavello I, Pampaloni F, Battaglia C, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med. 2016;13:1651–61.

    Article  PubMed  Google Scholar 

  33. Trompeter SE, Bettencourt R, Barrett-Connor E. Metabolic syndrome and sexual function in postmenopausal women. Am J Med. 2016;129(12):1270–1277.e1. doi:10.1016/j.amjmed.2016.03.039.

    Article  PubMed  Google Scholar 

  34. Clark NG, Fox KM, Grandy S, SHIELD Study Group. Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Diabetes Care. 2007;30:2868–73.

    Article  PubMed  Google Scholar 

  35. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab. 2009;94:4127–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31:1898–904.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Woodard GA, Brooks MM, Barinas-Mitchell E, Mackey RH, Matthews KA, Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women’s Health Across the Nation Heart Women. Menopause. 2011;18:376–84.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bagnoli VR, Fonseca AM, Arie WM, Das Neves EM, Azevedo RS, Sorpreso IC, et al. Metabolic disorder and obesity in 5027 Brazilian postmenopausal women. Gynecol Endocrinol. 2014;30:717–20.

    Article  CAS  PubMed  Google Scholar 

  40. Matsuda M, Shimomura I. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk. Horm Mol Biol Clin Investig. 2014;19:75–88.

    CAS  PubMed  Google Scholar 

  41. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care. 2004;27:689–94.

    Article  Google Scholar 

  42. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371:1927–35.

    Article  PubMed  Google Scholar 

  43. Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, et al. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol. 2010;55:2390–8.

    Article  PubMed  Google Scholar 

  44. Chedraui P, San Miguel G, Villacreses D, Dominguez A, Jaramillo W, Escobar GS, et al. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas. 2013;74:154–9.

    Article  PubMed  Google Scholar 

  45. Lin SC, Sun CA, You SL, Hwang LC, Liang CY, Yang T, et al. The link of self-reported insomnia symptoms and sleep duration with metabolic syndrome: a Chinese Population-Based Study. Sleep. 2016;39:1261–6.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Arora T, Chen MZ, Cooper AR, Andrews RC, Taheri S. The impact of sleep debt on excess adiposity and insulin sensitivity in patients with early type 2 diabetes mellitus. J Clin Sleep Med. 2016;12:673–80.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Akbaraly TN, Jaussent I, Besset A, Bertrand M, Barberger-Gateau P, Ritchie K, et al. Sleep complaints and metabolic syndrome in an elderly population: the Three-City Study. Am J Geriatr Psychiatry. 2015;23:818–28.

    Article  PubMed  Google Scholar 

  48. Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schürmann A, et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016;5(12):1175–86. doi:10.1016/j.molmet.2016.10.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and metaanalysis. Diabetes Care. 2012;35:2402–11.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Giugliano D. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine. 2014;45:28–36.

    Article  CAS  PubMed  Google Scholar 

  51. Hernandez AV, Pasupuleti V, Benites-Zapata VA, Thota P, Deshpande A, Perez-Lopez FR. Insulin resistance and endometrial cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2015;51:2747–58.

    Article  CAS  PubMed  Google Scholar 

  52. Gianuzzi X, Palma-Ardiles G, Hernandez-Fernandez W, Pasupuleti V, Hernandez AV, Perez-Lopez FR. Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: a systematic review and meta-analysis. Maturitas. 2016;94:22–9.

    Article  CAS  PubMed  Google Scholar 

  53. Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, et al. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Investig. 2008;66:14–7.

    Article  CAS  Google Scholar 

  54. Uimari O, Auvinen J, Jokelainen J, Puukka K, Ruokonen A, Järvelin MR, et al. Uterine fibroids and cardiovascular risk. Hum Reprod. 2016;31:2689–703.

    Article  PubMed  Google Scholar 

  55. Bueloni-Dias FN, Spadoto-Dias D, Delmanto LR, Nahas-Neto J, Nahas EA. Metabolic syndrome as a predictor of endometrial polyps in postmenopausal women. Menopause. 2016;23:759–64.

    Article  PubMed  Google Scholar 

  56. Otunctemur A, Dursun M, Ozbek E, Sahin S, Besiroglu H, Koklu I, et al. Impact of metabolic syndrome on stress urinary incontinence in pre-and postmenopausal women. Int Urol Nephrol. 2014;46:1501–5.

    Article  CAS  PubMed  Google Scholar 

  57. Bunn F, Kirby M, Pinkney E, Cardozo L, Chapple C, Chester K, et al. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract. 2015;69:199–217.

    Article  CAS  PubMed  Google Scholar 

  58. Esposito K, Chiodini P, Capuano A, Colao A, Giugliano D. Fracture risk and bone mineral density in metabolic syndrome: a meta-analysis. J Clin Endocrinol Metab. 2013;98:3306–14.

    Article  CAS  PubMed  Google Scholar 

  59. Muka T, Trajanoska K, Kiefte-de Jong JC, Oei L, Uitterlinden AG, Hofman A, et al. The association between metabolic syndrome, bone mineral density, hip bone geometry and fracture risk: the Rotterdam Study. PLoS One. 2015;10:e0129116.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Sun K, Liu J, Lu N, Sun H, Ning G. Association between metabolic syndrome and bone fractures: a meta-analysis of observational studies. BMC Endocr Disord. 2014;14:13.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Qu Y, Kang MY, Dong RP, Zhao JW. Correlations between abnormal glucose metabolism and bone mineral density or bone metabolism. Med Sci Monit. 2016;22:824–32.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ng TP, Feng L, Nyunt MS, Feng L, Gao Q, Lim ML, et al. Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol. 2016;73:456–63.

    Article  PubMed  Google Scholar 

  63. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, et al. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on aging. Neurobiol Aging. 2011;32:1932–41.

    Article  PubMed  Google Scholar 

  64. Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas. 2009;64:67–79.

    Article  PubMed  Google Scholar 

  65. Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14:2274–84.

    Article  PubMed  Google Scholar 

  66. Babio N, Toledo E, Estruch R, Ros E, Martínez-González MA, Castañer O, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ. 2014;186:E649–57.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos J, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57:1299–313.

    Article  CAS  PubMed  Google Scholar 

  68. Jones JL, Fernandez ML, McIntosh MS, Najm W, Calle MC, Kalynych C, et al. A Mediterranean-style low-glycemic-load diet improves variables of metabolic syndrome in women, and addition of a phytochemical-rich medical food enhances benefits on lipoprotein metabolism. J Clin Lipidol. 2011;5:188–96.

    Article  PubMed  Google Scholar 

  69. Godos J, Zappalà G, Bernardini S, Giambini I, Bes-Rastrollo M, Martinez-Gonzalez M. Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: a meta-analysis of observational studies. Int J Food Sci Nutr. 2016:1–11.

    Google Scholar 

  70. Rodríguez-Monforte M, Sánchez E, Barrio F, Costa B, Flores-Mateo G. Metabolic syndrome and dietary patterns: a systematic review and meta-analysis of observational studies. Eur J Nutr. 2016;56(3):925–47. PubMed PMID: 27605002.

    Article  PubMed  Google Scholar 

  71. Haring B, Crandall CJ, Wu C, LeBlanc ES, Shikany JM, Carbone L, et al. Dietary patterns and fractures in postmenopausal women: results from the Women’s Health Initiative. JAMA Intern Med. 2016;176:645–52.

    Article  PubMed  Google Scholar 

  72. Peluso I, Romanelli L, Palmery M. Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: diet or supplementation for metabolic syndrome prevention? Int J Food Sci Nutr. 2014;65:259–67.

    Article  CAS  PubMed  Google Scholar 

  73. Haro C, Montes-Borrego M, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, et al. Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population. J Clin Endocrinol Metab. 2016;101:233–42.

    Article  CAS  PubMed  Google Scholar 

  74. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8:e71108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Haro C, Garcia-Carpintero S, Alcala-Diaz JF, Gomez-Delgado F, Delgado-Lista J, Perez-Martinez P, et al. The gut microbial community in metabolic syndrome patients is modified by diet. J Nutr Biochem. 2016;27:27–31.

    Article  CAS  PubMed  Google Scholar 

  76. Moreno-Vecino B, Arija-Blázquez A, Pedrero-Chamizo R, Gómez-Cabello A, Alegre LM, Pérez-López FR, et al. Sleep disturbance, obesity, physical fitness and quality of life in older women: EXERNET Study Group. Climacteric. 2017;20(1):72–9.

    Article  CAS  PubMed  Google Scholar 

  77. Katz PP, Pate R. Exercise as medicine. Ann Intern Med. 2016;165(12):880–1. doi:10.7326/M16-2086.

    Article  PubMed  Google Scholar 

  78. Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, van Gaal L. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013;8:e56415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med. 2013;43:121–33.

    Article  PubMed  Google Scholar 

  80. Chilibeck PD, Pérez-López FR, Bodary PF, Kang ES, Jeon JY. Adipocytokines, metabolic syndrome, and exercise. Int J Endocrinol. 2014;2014:597162.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Nelson RK, Horowitz JF, Holleman RG, Swartz AM, Strath SJ, Kriska AM, et al. Daily physical activity predicts degree of insulin resistance: a cross-sectional observational study using the 2003–2004 National Health and Nutrition Examination Survey. Int J Behav Nutr Phys Act. 2013;10:10.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Tuna V, Alkiş I, Safiye AS, Imamoglu N, Bayram N, Ali IT. Variations in blood lipid profile, thrombotic system, arterial elasticity and psychosexual parameters in the cases of surgical and natural menopause. Aust N Z J Obstet Gynaecol. 2010;50:194–9.

    Article  PubMed  Google Scholar 

  83. Pérez-López FR, Chedraui P. Surgical prevention of epithelial ovary cancer without oophorectomy: changing the future. Climacteric. 2016;19:417–8.

    Article  PubMed  Google Scholar 

  84. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60:10–8.

    Article  CAS  PubMed  Google Scholar 

  85. Lobo RA. Metabolic syndrome, adipocytokines and estrogen therapy. Climacteric. 2005;8(Suppl 2):46.

    Google Scholar 

  86. Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2009;4:113–9.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Marotz CA, Zarrinpar A. Treating obesity and metabolic syndrome with fecal microbiota transplantation. Yale J Biol Med. 2016;89:383–8.

    PubMed  PubMed Central  Google Scholar 

  88. Hartstra AV, Bouter KE, Bäckhed F, Nieuwdorp M. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care. 2015;38:159–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Zaragoza Faculty of Medicine, Lozano Blesa University Hospital, Domingo Miral S/n, Zaragoza, 50009, Spain

    Faustino R. Pérez-López M.D., Ph.D.

  2. Institute of Biomedicine, Faculty of Medical Sciences, Catholic University of Santiago de Guayaquil, Guayaquil, Ecuador

    Peter Chedraui M.D., Ph.D.

Authors
  1. Faustino R. Pérez-López M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Chedraui M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faustino R. Pérez-López M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain

    Antonio Cano

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pérez-López, F.R., Chedraui, P. (2017). The Metabolic Syndrome in Mid-Aged Women. In: Cano, A. (eds) Menopause. Springer, Cham. https://doi.org/10.1007/978-3-319-59318-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59318-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59317-3

  • Online ISBN: 978-3-319-59318-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation